|
|
.
See Category: Neoplasms
See Header: Benign carcinoid tumors of the appendix, lg int, and rectum
ICD-10 (CM) Code and Descriptor
|
D3A.020 |
Benign carcinoid tumor of the appendix
|
D3A020 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 42.39%
|
24.80%
|
12.24%
|
5.34%
|
5.02%
|
3.30%
|
2.04%
|
1.10%
|
1.26%
|
1.10%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D3A.020*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
94
|
94
|
|
80053
|
COMPREHEN METABOLIC PANEL |
89
|
89
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
88
|
88
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
83
|
83
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
43
|
51
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
42
|
42
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
41
|
4,767
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
36
|
36
|
|
J1930
|
LANREOTIDE INJECTION |
24
|
2,880
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
24
|
760
|
|
82565
|
ASSAY OF CREATININE |
24
|
24
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
23
|
23
|
|
J9190
|
FLUOROURACIL INJECTION |
22
|
132
|
|
71260
|
CT THORAX DX C+ |
19
|
19
|
|
96360
|
HYDRATION IV INFUSION INIT |
19
|
19
|
|
84260
|
ASSAY OF SEROTONIN |
16
|
16
|
|
83497
|
ASSAY OF 5-HIAA |
16
|
16
|
|
G1004
|
CDSM NDSC |
13
|
19
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
13
|
16
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
13
|
23
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D3A.020 related to the following DRG Codes:
393-395
|
